关于“阿尔茨海默病药物研发与血脑屏障问题”的评论。阿尔茨海默病药物：不止一道需要突破的屏障。 - Suppr | 超能文献

Commentary on "Alzheimer's disease drug development and the problem of the blood-brain barrier." Alzheimer's disease drugs: more than one barrier to breach.

作者信息

Roher Alex E, Kokjohn Tyler A

机构信息

Banner Health/Sun Health Research Institute, Sun City, AZ, USA.

出版信息

Alzheimers Dement. 2009 Sep;5(5):437-8. doi: 10.1016/j.jalz.2009.07.037.

DOI:10.1016/j.jalz.2009.07.037

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Commentary on "Alzheimer's disease drug development and the problem of the blood-brain barrier." Alzheimer's disease drugs: more than one barrier to breach.关于“阿尔茨海默病药物研发与血脑屏障问题”的评论。阿尔茨海默病药物：不止一道需要突破的屏障。

Alzheimers Dement. 2009 Sep;5(5):437-8. doi: 10.1016/j.jalz.2009.07.037.

2

Commentary on "Alzheimer's disease drug development and the problem of the blood-brain barrier." The blood-brain barrier: a physical and conceptual challenge.关于“阿尔茨海默病药物研发与血脑屏障问题”的评论。血脑屏障：一个物理和概念上的挑战。

Alzheimers Dement. 2009 Sep;5(5):435-6. doi: 10.1016/j.jalz.2009.07.002.

3

Computational approaches to the prediction of blood-brain barrier permeability: A comparative analysis of central nervous system drugs versus secretase inhibitors for Alzheimer's disease.

Curr Opin Drug Discov Devel. 2006 May;9(3):303-13.

4

Targeted nanoparticles for drug delivery through the blood-brain barrier for Alzheimer's disease.用于通过血脑屏障进行阿尔茨海默病药物递送的靶向纳米颗粒。

J Control Release. 2005 Nov 28;108(2-3):193-214. doi: 10.1016/j.jconrel.2005.07.024. Epub 2005 Oct 24.

5

Commentary on "Alzheimer's Disease Drug Development and the Problem of the Blood-Brain Barrier".《关于“阿尔茨海默病药物研发与血脑屏障问题”的评论》

Alzheimers Dement. 2009 Sep;5(5):433-4. doi: 10.1016/j.jalz.2009.06.004.

6

Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease.聚（正丁基氰基丙烯酸酯）纳米颗粒，表面涂有聚山梨醇酯80，用于将卡巴拉汀靶向递送至脑部以治疗阿尔茨海默病。

Brain Res. 2008 Mar 20;1200:159-68. doi: 10.1016/j.brainres.2008.01.039. Epub 2008 Jan 26.

7

[Role of the blood-brain barrier in Alzheimer's disease].[血脑屏障在阿尔茨海默病中的作用]

Med Sci (Paris). 2011 Nov;27(11):987-92. doi: 10.1051/medsci/20112711015. Epub 2011 Nov 30.

8

Alzheimer's disease drug development and the problem of the blood-brain barrier.阿尔茨海默病药物研发与血脑屏障问题

Alzheimers Dement. 2009 Sep;5(5):427-32. doi: 10.1016/j.jalz.2009.06.003.

9

[The blood-brain barrier and drug delivery in the central nervous system].[血脑屏障与中枢神经系统中的药物递送]

Rev Neurol. 2010 Aug;51(3):165-74.

10

Targeted drug delivery to the brain; (blood-brain barrier, efflux, endothelium, biological transport).靶向药物递送至大脑；（血脑屏障、外排、内皮、生物转运）

J Drug Target. 2000;8(6):353-5. doi: 10.3109/10611860008997911.

引用本文的文献

1

The Oral-Gut-Brain AXIS: The Influence of Microbes in Alzheimer's Disease.口腔-肠道-脑轴：微生物在阿尔茨海默病中的影响

Front Cell Neurosci. 2021 Apr 14;15:633735. doi: 10.3389/fncel.2021.633735. eCollection 2021.

2

Receptor for advanced glycation end products up-regulation in cerebral endothelial cells mediates cerebrovascular-related amyloid β accumulation after Porphyromonas gingivalis infection.牙龈卟啉单胞菌感染后，脑内皮细胞中晚期糖基化终产物受体的上调介导了与脑血管相关的淀粉样 β 积累。

J Neurochem. 2021 Aug;158(3):724-736. doi: 10.1111/jnc.15096. Epub 2020 Jun 15.